Kymera Therapeutics KYMR
NASDAQ KYMR
$112.07 +0.28 (+0.25%)
As of: Oct 1, 2026 · 3:07 PM EDT

Kymera Therapeutics (KYMR) Other financing activities (2019 - 2026)

Updated

Kymera Therapeutics' Other financing activities came in at $436,000 for Q2 2026, up 14.1% from $382,000 a year earlier and up 2.6% from the prior quarter.

Analysis

Kymera Therapeutics (KYMR) Other financing activities (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Kymera Therapeutics reported Other financing activities of $1.7 million, up 6.5% year-over-year; for FY2025, it came in at $1.49 million, down 5.2% from FY2024.

  • Other financing activities carries a five-year compound annual growth rate of 21.9% (FY2020 to FY2025).
  • Going back by year, Other financing activities was $1.58 million in FY2024, $76,000 in FY2023 (-93.3%), $1.13 million in FY2022 (+33.1%) and $849,000 in FY2021 (+53.2%).
  • The Q2 2026 figure represents the highest quarterly Other financing activities since Q3 2024.
  • Year-over-year, Other financing activities has increased for three consecutive quarters, with growth averaging 23.9% over the last seven quarters.
  • The fastest year-over-year change in Other financing activities over five years came in Q3 2021 (growth of 222.9%), and the weakest in Q3 2025 (a decline of 34.6%).
  • Business Quant data shows KYMR's Other financing activities at $425,000 (Q1 2026), $416,000 (Q4 2025) and $419,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Kymera Therapeutics 9.25 Bn 6.56 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 436,000.00
Mar 31, 2026 425,000.00
Dec 31, 2025 416,000.00
Sep 30, 2025 419,000.00
Jun 30, 2025 382,000.00
Mar 31, 2025 277,000.00
Dec 31, 2024 293,000.00
Sep 30, 2024 641,000.00
Jun 30, 2024 352,000.00
Mar 31, 2024 290,000.00
Dec 31, 2023 -925,000.00
Sep 30, 2023 340,000.00
Jun 30, 2023 334,000.00
Mar 31, 2023 327,000.00
Dec 31, 2022 305,000.00
Sep 30, 2022 292,000.00
Jun 30, 2022 269,000.00
Mar 31, 2022 264,000.00
Dec 31, 2021 156,000.00
Sep 30, 2021 352,000.00
API Access

Kymera Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=KYMR&period=max&api_key=YOUR_API_KEY